Best Practice Day - 2 July 2025
The Best Practice Day for 2025 will be held in Cardiff on Wednesday 2nd July, and this year AWTTC are excited to be holding the event in partnership with the Yellow Card Centre (YCC) Wales. The event will have a focus on medicines safety, and will also provide plenty of opportunity to network and share ideas with colleagues from across Wales.
The full agenda is presented below or can be downloaded here.
Best Practice Day 2025 is open to all healthcare professionals with an interest in medicines safety. However, the event is now fully subscribed and AWTTC is no longer taking additional registrations.
Please email awttc@wales.nhs.uk if you would like to be added to the waiting list. Should a place become available we will then email you as soon as possible.
Read more about some of our previous Best Practice Days:
Phil Routledge graduated in medicine from Newcastle University in 1972. He trained in general medicine and clinical pharmacology in the North East of England, and in Vanderbilt and Duke Universities in the USA, before being appointed senior lecturer in Clinical Pharmacology in 1981 at the then Welsh National School of Medicine (now part of Cardiff University). He was appointed Professor of Clinical Pharmacology there in 1989. From 1981, he was an honorary consultant general physician/clinical pharmacologist/toxicologist at University Hospital Llandough, in Cardiff and, until his retirement in 2019, was Clinical Director of the All Wales Therapeutics and Toxicology Centre.
He has served on several MHRA regulatory committees and on appraisal committees of NICE. In 2005, he was appointed first Chairman of the newly-formed UK Herbal Medicines Advisory Committee, and a year later (until September 2014), Chairman of the All-Wales Medicines Strategy Group (AWMSG). In 2005, he was awarded the Lilly Prize by the British Pharmacological Society for distinction in clinical pharmacology over many years. He is a President Emeritus of the British Pharmacological Society, an Honorary Fellow of the Royal College of General Practitioners and the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He is a Fellow of the Learned Society of Wales. He was appointed Officer of the Order of the British Empire (OBE) in 2008, and Commander of the Order of the British Empire (CBE) in 2018, both for services to medicine.
Phil is a keen birdwatcher and gardener, and a lifelong supporter of Newcastle United Football Club, and an ardent supporter of Wales when it comes to the Rugby.
Dr Helen Cordy is part of the Metabolic Medicine team within Cardiff and Vale UHB. In her clinical work, she works within nutrition both in the Regional Intestinal Failure service and the tier 3 Specialist Weight Management Service (SWMS). The Cardiff SWMS sees close to 200 new patients a year and utilises an MDT approach for safe and effective patient care. She and her colleagues are also involved in undertaking research within the field, both locally and as part of wider commercial studies.
Dr Morrison works for National Poisons Information Service (Edinburgh) and NHS Lothian Medicines Management as a Consultant in Clinical Pharmacology. She graduated from the University of Glasgow in 2008, moving to the East coast of Scotland in 2010. While in Edinburgh, she has completed a PhD investigating to role of short RNAs in toxic injury. Dr Morrison has a career long interest in medicines governance, driven by a passion for healthcare equity and medicines safety. She chairs Lothian's Area Drug and Therapeutics Committee and is longstanding committee member of the Scottish Medicines Consortium (SMC).
Dr Gray is a Consultant Clinical Pharmacologist and Toxicologist working in Cardiff and Vale University Health Board (CAVUHB). He graduated in Wales, a member of the first cohort of graduate entry medicine at Swansea University.
Dr Gray is chair of the All Wales Prescribing Advisory Group (AWPAG), a group that feeds into All Wales Medicines Strategy Group (AWMSG) on issues relating to prescribing, medicines use and safety. He is also chair of the Medicines Safety Executive (MSE) at CAVUHB.
In addition, he is director of the National Poisons Information Service (NPIS) in Cardiff which supports healthcare staff manage poisoned patients.
He also leads the drug allergy service in CAVUHB and has helped produce All Wales guidance on penicillin allergy de-labelling.
Lelly Oboh is a Consultant Pharmacist for older people at Guy’s & St Thomas’ NHS Trust and Clinical & Care Professional Lead at South East London Integrated Care System, where she leads the implementation of the National Overprescribing Review recommendations across the system.
A Fellow of the Royal Pharmaceutical Society, Lelly is nationally recognised for her expertise in optimising medicines for older people living with frailty, multimorbidity, and polypharmacy. She is a sought-after speaker, educator, and contributor to national guidance in this area, and serves on advisory and research groups.
A passionate advocate for person-centred care, shared decision-making, and deprescribing, Lelly undertakes medicines reviews for patients with complex needs, aligning therapeutic aims with what matters most to them and enabling other clinicians to do the same.
As a clinical leader, she provides insights that challenge conventional practices to improve quality of care and outcomes, she drives innovation and reform, builds effective partnerships across organisations, integrated systems and disciplines, supports sustainable transformation within and beyond the NHS.
Lelly is currently a member of the NHSE National Overprescribing Advisory Group, NIHR funded Overprescribing research project advisory group and committee. She is a well sought after speaker, is well published in this subject area, and led several innovative local and national projects to reduce overprescribing and optimise medicines for older people.